Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cardiac Pharmacology 2017

Sessions/Tracks

Conference series LLC Conferences invites all the participants from all over the world to attend “6th Global Experts Meeting on Cardiology and Cardiovascular Pharmacology” during October 20-21, 2017 in Osaka,  Japan. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cardiac Pharmacology 2017 focusing on the advanced technologies to save heart and life.  Working with doctors, scientists, and other subject matter experts, creates awareness that effectively and clearly  explains Vascular interventions, Trans catheter valve technology, Congenital heart  treatments, Coronary interventions, Heart stroke prevention. Conferenceseries LLC organizes a conference series of 3000+ Global Events inclusive of 600+ Conferences, 1200+ Upcoming and Previous Symposiums and 1200+Workshops in USA, Europe & Asia with support from 1000 more scientific societies , 15 million unique visitors per year, 36 million page views per year. Publishes 700+ Open access Journals which contains over 70000 eminent  personalities, reputed scientists as editorial board members with 21 days rapid review process. To know more about the conference series visit: http://www.conferenceseries.com/

Track1: Cardiac Pharmacology

Heart is a muscular organ; it is size of a closed fist. Responsibility of heart is pumping blood through the blood vessels by recurrent, rhythmic contractions. The heart is consisting of cardiac muscle, an involuntary muscle tissue. The term "cardiac" means "related to the heart”. It is a four-chambered, double pump and is located in the thoracic cavity between the lungs. The cardiac muscle is own conduction system. This is in contrast with skeletal muscle, which requires either conscious or reflex nervous stimuli. The heart's rhythmic contractions occur instinctively, although heart rate can be changed by nervous or hormonal influence such as exercise or the perception of danger. 

Related Conferences:

International Conference on Cardiovascular Medicine August 01-02, 2106, UK; 14th International Conference on Clinical and Experimental Cardiology November 07-09 , 2016,  USA; International Conference on Ischemic Heart  Diseases  October 20-21, 2016, USA; 15th Cardiothoracic Meeting, December 08-09, 2106, USA;  Cardiology Issues in Younger Adults  September 15-24, 2016, Italy; Royal Society of Medicine; The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; European Society of Cardiology Congress August 27-31, 2016, Italy.World Heart Federation ( ISFC)European Association for Cardio-thoracic Surgery.

Track2: Types of Cardio Vascular Diseases

CVDs include diseases of the heart, vascular diseases of the brain and diseases of blood vessels. CVDs are responsible for over 17.3 million deaths per year and are the leading causes of death in the world .The different types of CVDs are listed below. CVDs due to atherosclerosis: Ischaemic heart disease or coronary artery disease.Cerebrovascular disease, Diseases of the aorta and arteries, including hypertension and peripheral vascular disease. Other CVDs  are Congenital heart disease, Rheumatic heart disease, Cardiomyopathies, Cardiac arrhythmias.

Related Conferences:

International Conference on Cardiovascular Medicine August 01-02, 2106,UK; International Conference on Hypertension & Health Care August 11-12, 2016, Canada ; 10th International Conference on Molecular & Cellular Cardiology August 22-24 Brazil; International Conference on Ischemic Heart  Diseases  October 20-21, 2016 Chicago, USA; 62nd Annual Conference on Association of Cardiovascular And Thoracic Surgeons  February 18-21, 2016, India; European Society of Cardiology Congress August 27-31, 2016, Italy ;  The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; American Heart Association (AHA)British Cardiac Society.

Track3:Cardiovascular Pharmacotherapy and Cardiovascular surgery

Cardiovascular Pharmacotherapy includes Treatment for Cardiovascular disease such as medication, surgery and other procedures. Cardiovascular disease treatments vary by condition. If one has a heart infection, he/she likely is given antibiotics. In general, treatment for heart disease commonly includes: Lifestyle changes like doing exercise regularly, maintaining a proper diet chat, Medications, surgery or Medical procedures. The aims of treatment are to relieve symptoms, lower the risk of blood clots forming, bring down risk factors in an effort to slow, stop, or reverse the build-up of plaque. To Prevent Cardiovascular Disease complications we have to get updated with the treatments of cardiovascular diseases and to do so we will organize Cardiology Conferences every year worldwide. Cardiovascular Surgery on the heart or vessels performed by cardiac surgeons. It is done to treat complications of ischemic heart disease (for example, coronary artery bypass grafting), correct congenital heart disease, or treat valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis. It also includes heart transplantation. The development of cardiac surgery and cardiopulmonary bypass techniques has reduced the mortality rates of these surgeries to relatively low ranks. The most common type of heart surgery is Coronary artery bypass grafting (CABG). CABG improves blood flow to the heart. Surgeons use CABG to treat people who have severe coronary heart disease (CHD).

Related Conferences:

13th European Cardiology Congress October 24-26,  2016, Spain;  International Conference on Angiology December 08-09, 2016,  USA; 14th International Conference on Clinical and Experimental Cardiology November 07-09 , 2016, USA;  International Conference on Hypertension  & Treatment  August 11-12,2016 Toronto, Canada; European Society of Cardiology Congress August 27-31, 2016, Italy ; European Association for Cardio-thoracic SurgeryBritish Cardiac Society; The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; International Society for Heart Research (ISHR).

Track4: Risk Factors for Cardiovascular Diseases

There are many risk factors associated with coronary heart disease and stroke. Some risk factors cannot be changed such as family history, ethnicity and age.  Other risk factors that can be treated or changed include tobacco exposure, high blood pressure (hypertension), high cholesterolobesity, physical inactivitydiabetesunhealthy diets, and harmful use of alcohol.In developing countries people are struggling with increasing rates of cardiovascular disease, they still face the scourges of poor nutrition and infectious disease. Cardiovascular disease is the leading cause of death in the developing world. There are different types of risk factors are Behavioural risk factors, Metabolic risk factors, Other risk factors.You will not necessarily develop cardiovascular disease if you have a risk factor.  But the more risk factors you have the greater is the likelihood that you will, unless you take action to modify your risk factors and work to prevent them compromising your heart health.

Relevant Conferences:

15th World Cardiothoracic Meeting December 08-09, 2016, USA; 14th Clinical & Experimental Cardiology conference November 14-16, 2016, USA ; Atherosclerosis Conference July 11-12, 2016, USA; Cardio Vascular Medicine Conference August 1-2, 2016, UK; Angiology Conference December 08-09, 2016, USA; 16th World Cardiology Conference December 08-10, 2016, UAE ;10th Molecular & Cellular Cardiology conference November 28-29, 2016 Brazil ; 13th European Cardiology Congress October 17-19, 2016, Italy ; Hypertension conference August 11-12, 2016, Canada ; European Society of Cardiology Conference August 27-31, 2016 , Italy ; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, USA; European Cardiology Congress August 27-31, 2016,Italy ; American Cardiology association conference April 02-04, 2016, USA; Pre HT 2016 - The fourth International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome, Italy; WCC 2016 - World Congress of Cardiology and Cardiovascular Health, Mexico.International Society for Heart Research (ISHR)International Task Force for Prevention of Coronary Heart DiseaseItalian Society of Cardiology.

Track5: Interventional Cardiology

Interventional cardiology is a branch of cardiology refers specific Cather based techniques to various structural heart diseases, non-surgical procedures for treating cardiovascular disease. Interventional cardiologists use catheters – thin, flexible tube to repair damaged vessels or other heart structures, often avoiding the need for surgery. Many procedures can performed on heart by Catheterization. This most commonly involves the insertion of a sheath into the femoral artery and cannulating the heart under X-ray visualization. Cardiac catheterization is a test which used to evaluate your coronary arteries and heart valve function.

Relevant Conferences:

14th Clinical & Experimental Cardiology conference November 14-16, 2016, USA ;  Cardio Vascular Medicine Conference August 1-2, 2016, UK; Angiology Conference December 08-09, 2016, USA; 16th World Cardiology Conference December 08-10, 2016, UAE ;  10th Molecular & Cellular Cardiology conference November 28-29, 2016, Brazil ; 13th European Cardiology Congress October 17-19, 2016, Italy ; Hypertension conference August 11-12, 2016, Canada ;  European Society of Cardiology Conference August 27-31, 2016, Italy ; 8th Annual The Heart Beat of Cardiology December 10-12, 2016, USA; European Cardiology Congress August 27-31, 2016,Italy ; American Cardiology association conference  2016, USA (PreHT 2016).European Association for Cardio-thoracic SurgeryWorld Health OrganizationWorld Heart Federation ( ISFC).

Track6: Nuclear cardiology and Echocardiography

Echocardiography is a diagnostic test that uses ultrasound waves to create an image of the heart muscle. Ultrasound waves that echo off the heart can show the size, shape, and movement of the heart's valves and chambers as well as the flow of blood through the heart. Echocardiography shows abnormalities as poorly functioning heart valves or damage to the heart tissue from a past heart attack. Echocardiography is used to diagnose certain cardiovascular diseases. In fact, it is one of the most widely used diagnostic tool for heart diseases. It can provide a wealth of helpful information of diseased condition of heart. The conference reaches out the vivid topics in the field of echocardiography. Nuclear cardiology is non-invasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Myocardial perfusion imaging is the most widely used technique of nuclear cardiology. Myocardial perfusion images are combined with exercise to assess the blood flow to the heart muscle. Exercise is most often in the form of walking on the treadmill. A "chemical" of "pharmacological" stress test using the drug dipyridamole, adenosine or dobutamine is performed in patients who are not able to exercise maximally, providing similar information about the heart's blood flow.

Relevant Conferences:

13th European Cardiology Congress October 24-26,  2016, Spain;  International Conference on Angiology December 08-09, 2016,  USA; 14th International Conference on Clinical and Experimental Cardiology November 07-09 , 2016, USA;  International Conference on Hypertension  & Treatment  August 11-12,2016 Toronto, Canada; European Society of Cardiology Congress August 27-31, 2016, Italy ;  The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; World Heart Federation (ISFC)International Society for Heart Research (ISHR)British Cardiac Society.

Track7: Cerebrovascular heart Diseases

Cerebral vascular disease is caused by atherosclerosis, that is the narrowing and blockage of the blood vessels that flow to the brain. If the flow of blood is cut off this can lead to strokes and transient ischemic attacks.Brain Stroke A stroke occurs when the blood supply to the brain is interrupted. It happens either when a blood vessel in the brain or neck is blocked or bursts or brain is deprived of oxygen and parts of brain may be permanently damaged. The consequences of a stroke can include problems with speech or vision, weakness or paralysis.Transient ischemic attacks Just as stroke occurs when the flow of blood is blocked, TIAs happen when there is a brief blockage. The temporary loss of blood to the brain causes a brief, sudden change in brain function.  This may manifest as temporary numbness or weakness on one side of the body, loss of balance, confusion, and blindness in one or both eyes, double vision, difficulty speaking, or a severe. But these will disappear quickly and permanent damage is unlikely.Dementia The additive effects of multiple small strokes, together with microangiopathy affecting the small blood vessels to the brain, lead to an increased likelihood of dementia in people with diabetes.

Relevant Conferences:

International Conference on Cardiovascular Medicine August 01-02, 2106, UK; 14th International Conference on Clinical and Experimental Cardiology November 07-09 , 2016,  USA; International Conference on Ischemic Heart  Diseases  October 20-21, 2016, USA; 15th Cardiothoracic Meeting, December 08-09, 2106, USA;  Cardiology Issues in Younger Adults  September 15-24, 2016, Italy; Royal Society of Medicine; The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; European Society of Cardiology Congress August 27-31, 2016, Italy.World Heart Federation ( ISFC)European Association for Cardio-thoracic Surgery.

Track 8:  Complications of diseases associated Cardiovascular Diseases

Diabetes can lead to cardiovascular damage in a number of ways. The processes do not develop independently, as each may accelerate or worsen the others. Thus, as diabetes progresses, the heart and blood vessels are exposed to multiple attacks. The cardiovascular complications of diabetes are therefore a major cause of illness, death and healthcare costs. Cardiovascular death rates are either high or appear to be climbing in countries where diabetes is prevalent.People with type 2 diabetes also have high rates of high blood pressure, lipid problems, and obesity, which contribute to their high rates of CVD. Smoking doubles the risk of CVD in people with diabetesHypertensionIt is a risk factor for coronary heart disease and the single most important risk factor for   stroke. There are at least 970 million people worldwide who have hypertension. It causes about 50% of ischaemic strokes and increases the risk of haemorrhagic stroke. Hypertension stresses human body’s blood vessels, causing them to clog or weaken.  Hypertension can lead to atherosclerosis and narrowing of the blood vessels making them more likely to block from blood clots or bits of fatty material breaking off from the lining of the blood vessel wall. Chronic kidney disease (CKD) is a worldwide public health problem. Kidney failure requiring treatment with dialysis or transplantation is the most visible outcome of CKD. However, cardiovascular disease (CVD) is also frequently associated with CKD, which is important because individuals with CKD are more likely to die of CVD than to develop kidney failure, CVD in CKD is treatable and potentially preventable, and CKD appears to be a risk factor for CVD. CKD exposes the heart to three major mechanisms that  Facilitate the development of cardiomyopathy, LV failure: pressure overload, volume overload.The plasma lipoproteins are the primary means of transport of cholesterol among tissues. In particular, the apo B-containing lipoproteins (VLDL, IDL and LDL) are important for the delivery of cholesterol from the liver to peripheral tissues, while HDL appear to mediate the reverse process of movement of cholesterol from tissues back to the liver. Both of these transport processes are necessary for efficient whole body cholesterol homeostasis, because the liver is the major site of both the production and excretion of cholesterol. However, deviations from a proper balance of transport of cholesterol, either increases in LDL levels or decreases in HDL cholesterol flux, may result in accumulation of cholesterol in extra hepatic tissues. Increased risk of atherosclerosis and CHD may be associated with elevation in the number of LDL particles, increase or decrease in LDL particle size, or changes in the composition of plasma LDL.

Relevant Conferences:

Ischemic Heart Diseases Conference October 20-21, 2016, USA; Hypertension & Health Care Conference August 11-12, 2016, Canada; 11th Cardiac Conference September 12-13, 2016, USA; 13th European Cardiology Congress  October 17-19, 2016, Italy; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016;  European Cardiology Congress August 27-31, 2016 Rome,  Italy; 21st World Congress on Heart Disease,  July 30-August 1, 2016, USA; Cardiac Society of Australia and New ZealandEuropean Association for Cardio-thoracic SurgeryInternational Academy of Cardiology (IAC).

Track 09: Heart diseases in different Rationale 

Although CVD has sometimes been considered a disease that predominantly affects men, it is the leading cause of death among both men and women globally. There are number of notable gender differences in CVD incidence, mortality, risk-factor profiles, outcomes, and clinical presentation. These differences remain consistent across populations and regions and are thus important to consider when developing CVD prevention and treatment programs.

Relevant Conferences:

International Conference on Cardiovascular Medicine August 01-02, 2106, UK; 14th International Conference on Clinical and Experimental Cardiology November 07-09 , 2016,  USA; International Conference on Ischemic Heart  Diseases  October 20-21, 2016, USA; 15th Cardiothoracic Meeting, December 08-09, 2106, USA;  Cardiology Issues in Younger Adults  September 15-24, 2016, Italy; Royal Society of Medicine; The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; European Society of Cardiology Congress August 27-31, 2016, Italy.World Heart Federation ( ISFC)European Association for Cardio-thoracic Surgery.

Track 10: Cardiologists and Angiologists

Cardiologists are physicians or doctors who specialize in treating diseases or conditions of the heart and diagnosing the whole blood vessels i.e. cardiovascular system. One must visit a cardiologist so they can learn about their risk factors for Cardiac or heart disease and find out what measures should be taken for better heart health. When one is dealing with heart disease, it is important that they must find the right match between them and their specialist and for that, basic knowledge on cardiology is much needed. To make it possible Cardiology Conferences are organised to spread the awareness to control this heart related sufferings and problems.

Cardiovascular Medicine Conference August 01-02, 2016, UK; 11th International Cardiac conference September 14-15, 2016,USA; 15th World Cardiothoracic Meeting December 08-09, 2016, USA; American Cardiology Congress2016; ACC Annual Meeting 2016; American Cardiology Congress 2016;  European Cardiology Congress August 27 - 31 ,2016 Italy;  International conference and Expo on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE; 21st World Congress on Heart Disease,  July 30-August 1, 2016, USA; Royal Society of MedicineThe American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)Austrian Society of Cardiology.

 

Track`11: Emerging epidemic of cardiovascular disease in developing countries

As the 20th century era to a close, Cardiovascular disease (CVD) becomes a ubiquitous cause of morbidity and a principal contributor to mortality in most countries. The major risk factors through population-based studies and effective control approaches combining community education and targeted management of high risk individuals added to the fall in CVD mortality rates that observed in almost all industrialized & modernized countries.

Relevant Conferences:

Cardio Vascular Medicine Conference August 1-2, 2016, UK; Angiology Conference December 08-09, 2016, USA; 16th World Cardiology Conference December 08-10, 2016, UAE ; Echo Cardiography Conference July 18-19, 2016, Germany; 10th Molecular & Cellular Cardiology conference November 28-29, 2016 Brazil ; 13th European Cardiology Congress October 17-19, 2016, Italy ; Hypertension conference August 11-12, 2016, Canada ; European Society of Cardiology Conference August 27-31, 2016 , Italy ; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, USA; European Cardiology Congress August 27-31, 2016,Italy ; Pre HT 2016 - The fourth International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome, Italy; WCC 2016 - World Congress of Cardiology and Cardiovascular Health, Mexico; Society for Cardiac Angiography & InterventionsWorld Heart Federation (ISFC)American Heart Association (AHA).

Track12:  Cardio toxicity

Cardio toxicity is the occurrence of heart electrophysiology dysfunction or muscle damage. The heart becomes weaker and is not as efficient in pumping and therefore circulating blood. Cardio toxicity may be caused by chemotherapy. Treatment complications are anorexia nervosa, adverse effects of heavy metals intake, or an incorrectly administered drug such as bupivacaine. One of the ways to detect cardio toxicity at early stages when there is a sub conical dysfunction is by measuring changes in regional function of the heart using strain.

Related conferences: 

Ischemic Heart Diseases Conference October 20-21, 2016, USA; Hypertension & Health Care Conference August 11-12, 2016, Canada; 11th Cardiac Conference September 12-13, 2016, USA; 13th European Cardiology Congress  October 17-19, 2016, Italy; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016;  European Cardiology Congress August 27-31, 2016 Rome,  Italy; 21st World Congress on Heart Disease,  July 30-August 1, 2016, USA; Italian Society of CardiologyEuropean Association for Cardio-thoracic SurgeryCardiac Society of Australia and New Zealand

Track 13: Cardiovascular regeneration and tissue engineering

Stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise non reversible, myocardial failure. The current clinical management of cardiac ischemia deals with re-establishing perfusion to the heart but not dealing with the irreversible damage caused by the occlusion or stenosis of the supplying vessels. The applications of these new technologies are not yet fully established as part of the management of cardiac diseases but will become so in the near future. The discussion presented here reviews some of the pioneering works at this new frontier. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrow-derived, adipose-derived, and resident cardiac stem cells.

Related conferences: 

Ischemic Heart Diseases Conference October 20-21, 2016, USA; Hypertension & Health Care Conference August 11-12, 2016, Canada; 11th Cardiac Conference September 12-13, 2016, USA; 13th European Cardiology Congress  October 17-19, 2016, Italy; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016;  European Cardiology Congress August 27-31, 2016 Rome,  Italy; 21st World Congress on Heart Disease,  July 30-August 1, 2016, USA; Italian Society of CardiologyEuropean Association for Cardio-thoracic SurgeryCardiac Society of Australia and New Zealand

Track14: Case Reports on Cardiology

Our all Cardiology conferences has Case Studies act as informative examples to people who might also faces similar problems. Generally, Case Studies in Cardiovascular disease, should detail a particular medical case, reporting the background of the patient. They should discuss investigations undertaken in order to determine a diagnosis or differentiate between possible diagnoses, and should indicate the type of treatment the patient underwent as a result. In one piece we can conclude that Case Studies is an useful and informative part of every doctor or physician's medical education, which actually encourage us to include this session track on our

Related Conferences

International Conference on Cardiovascular Medicine August 01-02, 2106, UK; 14th International Conference on Clinical and Experimental Cardiology November 07-09 , 2016,  USA; International Conference on Ischemic Heart  Diseases  October 20-21, 2016, USA; 15th Cardiothoracic Meeting, December 08-09, 2106, USA;  Cardiology Issues in Younger Adults  September 15-24, 2016, Italy;  The Cardiac Society of Australia and New Zealand ASM August 4-7, 2016; European Society of Cardiology Congress August 27-31, 2016, Italy; The American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)Austrian Society of CardiologyWorld Heart Federation (ISFC).

Track15: Cardiovascular Nursing

Cardiovascular nursing is a specialty that works with patients who suffer from numerous conditions of the cardiovascular system. Cardiovascular nurses facilitate treat conditions like unstable angina, myocardial infarction, cardiomyopathycoronary artery disease, cardiac dysrhythmia and congestive heart failure under the direction of a heart specialist (cardiologist). Cardiovascular nurses perform postoperative care on a stress test evaluations, cardiac monitoring, surgical unit, health assessments and vascular monitoring. Cardiovascular nurses must have Advanced Cardiac Life Support and Basic Life Support certification. Cardiovascular nurses must possess specialized skills including defibrillation, electrocardiogram monitoring and medication administration by continuous intravenous drip. Cardiovascular nurses care for people with Cardiovascular Disease and interact with their patients families. They may monitor and treat acutely ill patients, or they may focus on cardiovascular rehabilitation helping patients make lifestyle changes to prevent the worsening of their disease.

Relevant Conferences:

 Cardio Vascular Medicine Conference August 1-2, 2016, UK; Angiology Conference December 08-09, 2016, USA; 16th World Cardiology Conference December 08-10, 2016, UAE ; Echo Cardiography Conference July 18-19, 2016, Germany; 10th Molecular & Cellular Cardiology conference November 28-29, 2016 Brazil ; 13th European Cardiology Congress October 17-19, 2016, Italy ; Hypertension conference August 11-12, 2016, Canada ;  European Society of Cardiology Conference August 27-31, 2016 , Italy ; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, USA; European Cardiology Congress August 27-31, 2016,Italy ; Pre HT 2016 - The fourth International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome, Italy; WCC 2016 - World Congress of Cardiology and Cardiovascular Health, Mexico; World Heart Federation( ISFC)Royal Society of MedicineInternational Society for Heart Research (ISHR).

Track16: Clinical trials in Cardiology

Clinical trials in cardiology research investigations are being conducted in which people of cardiac failures or disorders volunteer to test new treatments, interventions or tests as a means to prevent, detect, treat or manage various cardiovascular diseases or medical conditions. Some investigations look at how people respond to a new intervention and the side effects which might occur. This helps to determine if a new intervention works, if it is safe, and if it is better than the interventions that are already available. Clinical trials might also compare existing interventions, test new ways to use or combine existing interventions or observe how people respond to other factors that might affect their health such as dietary changes.Angiologists are physicians or doctors who specialize in treating diseases or conditions of the circulatory system, lymphatic system (arteries, veins and lymphatic vases)

Related conferences:

Cardiovascular Medicine Conference August 01-02, 2016, UK; 11th International Cardiac conference September 14-15, 2016,USA; 15th World Cardiothoracic Meeting December 08-09, 2016, USA; American Cardiology Congress2016; ACC Annual Meeting 2016; American Cardiology Congress 2016;  European Cardiology Congress August 27 - 31 ,2016 Italy;  International conference and Expo on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE; 21st World Congress on Heart Disease,  July 30-August 1, 2016, USA; Royal Society of MedicineThe American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)Austrian Society of Cardiology.

Track17: Cardiovascular Drugs Market Analysis

We will examine recent variability and statistics regarding survival rates from cardiac arrest and industries related to Cardiovascular Medicine which will focus on challenging areas of research and it will assist us to steps ahead to improve the quality of care for cardiac problems like heart arrest etc. To meet the increasing demand for cardiovascular services and to ensure excellence in cardiac care delivery, on a series of upgrades and renovations that will enhance its ability to provide not only prompt also expert medical treatment, and even the best patient experience possible. This study will focus on the following topics: 3-D “Bioprinter, Information Technology, Thrombolytic [clot-busting] drug, Mobile Cardiovascular medicine apps, Social Media and Cardiovascular Medicine.

Relevant Conferences:

 14th Clinical & Experimental Cardiology conference November 14-16, 2016, USA ;  Cardio Vascular Medicine Conference August 1-2, 2016, UK; Angiology Conference December 08-09, 2016, USA; 16th World Cardiology Conference December 08-10, 2016, UAE ; 10th Molecular & Cellular Cardiology conference November 28-29, 2016, Brazil ; 13th European Cardiology Congress October 17-19, 2016, Italy ; Hypertension conference August 11-12, 2016, Canada ;  European Society of Cardiology Conference August 27-31, 2016, Italy ; 8th Annual The Heart Beat of Cardiology December 10-12, 2016, USA; European Cardiology Congress August 27-31, 2016,Italy ;American Cardiology association conference  2016, USA (PreHT 2016)German Cardiac Society (GCS)European Association for Cardio-thoracic SurgeryBritish Cardiac SocietyAmerican Heart Association (AHA).

About Conference

Conference Series LLC is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing forth Global Experts Meeting on Cardiology and Cardiovascular Pharmacology” (Cardiac Pharmacology 2017) scheduled to be held during October 20-21, 2017 at Osaka, Japan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Cardiovascular System and Medication.

Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

2017 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Cardiac Pharmacology 2017 is comprised of 17 tracks designed to offer comprehensive sessions that addresses current issues in Cardiovascular diseases. Conference Series LLC  organizes 300+conferences, 500+workshops such as electrocardiography workshops, CVDs diagnosis workshops, cardio myopathy workshops cardiology exhibitions and 200+symposiums on ClinicalMedicinePharma and Science & Technology. 

This conference will provide a comprehensive update on all medical, surgical, interventional, and electrophysiological topics in Cardiovascular diseases and Medication. Experts with national and international reputations in various cardio sub-specialties will address the latest guidelines, practice patterns and solutions in cardiovascular medicine. Additionally, attendees will learn about recent trials being practiced that are likely to influence future practices. Interactive sessions will include discussion of current controversies in clinical practice. The areas of Cardiac Pharmacology 2017 will be covered include: heart disease, imaging, heart failure, arrhythmias, prevention and general cardiology, cardiovascular surgery, Clinical research In CVDs and interventional cardiology.

Cardiac Pharmacology events are every year across USA, Europe, Asia, Middle East, Australia and UK that support cardiology medical conferences from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

 According to the American Heart Association, there are approximately 6000 hospitals in the US with only 23,000 cardiologists to cover 6000 hospitals, there’s no doubt that there is a current shortage of cardiologists in the US.

With continuing advances in all areas of cardiovascular medicine, there is a need to update general and sub-specialist cardiologists on the state of the art, rapidly-evolving developments in the field. Upon completion of this course, participants should have an increased understanding of changes in practice standards and recent clinical advancements in cardiovascular medicine. An additional objective of this meeting is to provide practical knowledge and tips to improve the practice of CVDs and Medication. This conference will benefit all levels of cardiology practitioners, including doctors, professors, nurses, PhD scholars and technicians.

Cardiac Pharmacology2017 invites all interested participants to join us for this esteemed event at the exquisite destinationDubai. For more information: conference series.com

Why to attend?

6th Global Experts Meeting on Cardiovascular Pharmacology and Cardiac Medications is among the World's leading Scientific Conference. The three day event on Cardiovascular Diseases and Medication  will host 60+ Scientific and technical sessions and sub-sessions on cutting edge research and latest research innovations in the field of cardiology and cardiac surgeries across the globe. This year annual Cardiac conference will comprises of 13 major sessions designed to offer comprehensive sessions that address current issues in various field of CVDs. The attendees can find-

Exclusive Sessions and Panel discussions on latest innovations in Cardiac Surgeries and Heart Failure-

Lectures by active practitioners
Keynote forums by Prominent Professors, Doctors
Open Innovation Challenges
Poster presentations by Young Researchers
Global Networking sessions with 50+ Countries
Novel techniques to benefit your research
Best platform for Global business and Networking opportunities
Meet the editors of referred journals, Society and Association members across the Globe
Excellent platform to showcase the latest products and formulations in Cardiac field

Target Audience:

  • Cardiologists
  • Cardiac Surgeons
  • University Professors
  • Various Societies and their members
  • Institutes-Medical Schools
  • Academicians: University Faculties, Research Scholars, and Scientists involved

Market Analysis

               Title: 6th Global Experts Meeting on Cardiology and Cardiovascular Pharmacology

Date & Venue: October 20-21, 2017 Osaka, Japan

Theme: Drugs Affecting the Rhythm of the Heart

Summary of Cardiac Pharmacology 2017 Conference:-

Cardiac Pharmacology 2017 is a platform for advanced technologies and provides a complete knowledge of a scientific discipline that describes the future and present trends in Cardiac research field and comprehensive update on all medical, surgical, interventional, and electrophysiological topics in cardiology. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional methods used in Cardiology and Cardiovascular Pharmacology. All Organizing Committee members of the Cardiac Pharmacology 2017 look forward to meet you in Osaka, Japan.

Scope and Importance:-

Cardiac Pharmacology 2017 will be the best platform for all the scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, students who are working in this field to exchange their knowledge related to Cardiology and Cardiac Surgery. This international event is an effort to find an alternative for invasive imaging technique against heart diseases and heart failure conditions in adults & children.

A prospective survey of patients with valvular heart disease (VHD):

·         Coronary angiography was used in 85.2% of patients before intervention.

·         The Euro Heart Survey (EHS) programme has been initiated order to provide quantitative information on cardiovascular disease.

·         To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease, and develop appropriate models for healthy CV lifestyle.

About Venue:

Osaka is Japan’s third largest and second most important city with a population of 2.5 million. It has been the economic powerhouse of the Kansai region for many centuries. The city’s west side has the main port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky building and the Tempozan Harbour Village. Osaka is known for its food, both in Japan and abroad. Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka has also been known as the “Nation’s Kitchen”.

Osaka is a large port city and commercial center on the Japanese island of Honshu. It's known for its modern architecture, nightlife and hearty street food. The 16th-century shogunate Osaka Castle, which has undergone several restorations, is its main historical landmark. It's surrounded by a moat and park with plum, peach and cherry-blossom trees. Sumiyoshi-taisha is among Japan’s oldest Shinto shrines.

Greatest Achievements in the Field of Cardiology:

  • Electrocardiography
  • Cardiac catheterization
  • Coronary angiography
  • Cardiovascular surgery
  • Invasive cardiology
  • The coronary care unit
  • Cardiovascular drugs
  • Preventive cardiology
  • Echocardiography
  • Cardiac Imaging Techniques
  • Pacemakers and internal defibrillators

Conference Highlights:

 

·         Cardiac Pharmacology

·         Heart Diseases and Failure

·         Cardiovascular Pharmacotherapies, Cardiac Procedures and surgeries

·         Risk Factors for Cardiovascular Diseases

·         Interventional Cardiology

·         Nuclear Cardiology and Echocardiography

·         Cerebrovascular Heart Diseases

·         Diseases associated with Cardiovascular Diseases    

·         Heart Diseases in Different Rationale

·         Cardiologists and Angiologists

·         Emerging epidemic of cardiovascular disease in developing countries

·         Cardiotoxicity

·         Cardiovascular and biological tissue regeneration and tissue engineering

·         Case Reports on Cardiology

·         Cardiovascular Nursing

·         Clinical trials in Cardiology

·         Cardiovascular drug market Analysis

Target Audience:

·         Academicians

·         Directors of Cardiovascular Pharmacology department in Universities

·         Cardiologists

·         Cardiac Surgeons

·         Research laboratories

·         Professors and Associate professors

·         Assistant professors

·         Lecturers

·         Graduates and Post Graduates

·         Research scholars

·         Research and Development Department

·         Ph.D. Students

·         Scientists

Why to attend???

Meet Your Target Market With members from around the world focused on learning about latest innovations in screening and treatments for heart diseases; this is your single best opportunity to reach the largest assemblage of participants from the Universities, Cardiology research centers and hospitals and conduct demonstrations of new screening instruments, distribute information about novel agents and strategies, meet with highly affiliated speakers, showing of clinical trials as well as advancements in new heart care therapies, current methods and controversies in cardiac therapy and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques for screening as well as for treatment, and the newest updates in Heart diseases and treatments are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event -

http://cardiac.pharmaceuticalconferences.com/


Growth of Cardiology Market:-

North America is the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2013, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share

 

Top-Ranked Hospitals for Cardiology & Heart Surgery:

Globally:

·         Cleveland Clinic, Ohio

·         Mayo Clinic, Rochester

·         New York-Presbyterian University Hospital of Columbia and Cornell, New York

·         Duke University Hospital, Durham

·         Brigham and Women's Hospital, Boston

·         Massachusetts General Hospital, Boston

·         Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia

·         Cedars-Sinai Medical Center, Los Angeles

·         St Francis Hospital, Roslyn, New York

·         Mount Sinai Hospital, New York

Japan:

·         Keio University Hospital – Tokyo

·         Yokohama City University Medical Center – Yokohama

·         National Cancer Center – Tokyo, Japan

·         Nagoya City West Medical Center, Nagoya

·         Osaka University Hospital – Suita, Osaka

·         University of Tokyo Hospital – Tokyo, Japan

·         St. Luke’s International Hospital – Tokyo, Japan

·         Jutendo University Hospital – Tokyo, Japan

·         International Catholic Hospital (Seibo Hospital) – Tokyo, Japan

·         Tokyo Medical University Hospital – Tokyo, Japan 

Osaka:

•      Osaka University Hospital – Suita, Osaka

•      Sumitomo Hospital, Osaka

•      Osaka National Hospital

•      Osaka Medical Centre for Cancer and Cardiovascular Diseases

•      Osaka Rosai Hospital

•      Osaka Red Cross Hospital

•     Osaka Prefectural Hospital Organization

Market Value of Cardiology:-

The World Heart Federation (WHF) unites 200 members spanning 100 countries in the fight against cardiovascular disease Global Data research predicts the worldwide market for CMD devices will reach $1.2 billion by 2017. The global cardiovascular device industry is growing rapidly and is said that a growth of $15billion is made from 2010-2015 as per BCC research. Products included in this market are electrocardiograph monitoring equipment, which is set to see 4% growth by 2017 to be worth over $410 million

Market Growth of Cardiology Research in the last and upcoming years:

The arthroscopy market, which covers 39 countries and includes implant and capital equipment, is set to rise from $4.19 billion in 2016 to $5.73 billion by 2023, representing  a compound annual growth rate (CAGR) of 4.6%, according to research and consulting firm Global Data.

 

The cardiac marker point-of-care (POC) market is expected to rise across the 15 major markets of the US, Canada, Mexico, France, Germany, Italy, Spain, Russia, the UK, Japan, China, India, South Korea, Australia, and Brazil, from around $311 million in 2016 to almost $398 million by2023, representing a compound annual growth rate of 3.6%, according to GD Research global data.

 

Products manufactured by the industry related to Cardiology research in Japan:

·         Pacemakers,

·         Implantable defibrillators,

·         Stents

·         Remote patient management.

·         Vascular/Surgical Devices

·         Small Molecules


Products manufactured by the industry related to Cardiology research Globally:-

·         Pacemakers

·         Implantable defibrillators Stents

·         Remote Patient Management.

·         Vascular/Surgical Devices

·         Small Molecules

·         Heart valve corrective device

·         Stents

·         Specialized medicines;

·         Medical Diagnostic Instruments.

·         Single-use cardiovascular medical devices

 

Bibliography:-

https://www.globaldata.com/2017/01/28/arthroscopy-market-to-surpass-5-7-billion-by-2023-as-sports-injuries-are-on-the-rise-says-globaldata-2/

https://www.globaldata.com/2016/12/29/cardiac-marker-point-of-care-market-will-approach-400-million-by-2023-says-globaldata/

 

 

Past Conference Report

Cardiologists 2016

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, Conference Series LLC 8th Global Cardiologists and Echocardiography Annual Meeting was held during July 18-20, 2016 in Berlin, Germany.

Conference Series LLC Group played host to a diverse panel of key members of the Cardiologists & Echocardiography community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardiological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiologists, Pediatric Cardiology, Heart Diseases, Echocardiography, Interventional Cardiology, Heart and Blood Vessel Surgeries, Cardiac Nursing, Diabetes and the Heart and Heart Failure as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiologists & Echocardiography-2016 Organizing Committee would like to thank the Moderators of the conference, Dr. Irena Levitan, University of Illinois, USA and Dr. Aris Lacis, University Children Hospital, Latvia who contributed a lot for the smooth functioning of this event.

The highlights of the meeting were the eponymous lectures, delivered by Ada Yonath Nobel Laureate 2009 from Weizmann Institute of Science, Isarel, Raimund Erbel from University Duisburg-Essen, Germany, Jens Frahm from Max-Planck-Institut für Biophysikalische Chemie ,Germany, Guy Hugues Fontaine from Universite Pierre et Marie Curie, France, Roland Hetzer from Former Medical Director, German Heart Institute, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

Conference series LLC 8th Global Cardiologists and Echocardiography Annual Meeting was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access. We are happy to announce our 17th Global Cardiologists Annual Meeting, which will be held during June 19-21, 2017 in Paris, France.


Past Reports  Proceedings  Gallery  

Pharmacology 2016

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Pharmacology 2016 a wonderful event!

Conference Series LLC hosted 3rd World Congress on Pharmacology scheduled during August 08-10, 2016at Holiday Inn Birmingham City Centre, Birmingham, UK with the theme “(New) Drug Discovery: Multiple Trails towards a Broadway"

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

  • Pharmacology
  • Neuropharmacology
  • Psychopharmacology
  • Advances in Pharmacological Research
  • Ethnopharmacology
  • Toxicology
  • Drug Screening and Discovery
  • Pharmacokinetics and Pharmacodynamics
  • Biochemical Pharmacology
  • Pharmacological Testing

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

  • CEJ van Rensburg (Connie Medlen), University of Pretoria, South Africa
  • Karen Mulkijanyan, Tbilisi State Medical University, Georgia
  • Alexander Kulikov, Siberian Division of Russian Academy of Sciences, Russia
  • Walber Toma, Santa Cecilia University, Brazil
  • P Brindha, SASTRA University, India
  • Myung Koo Lee, Chungbuk National University, Republic of Korea

Conference series LLC thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

With the grand success of Pharmacololgy-2016, Conference Series LLC take the immense pleasure to announce the “9th World Congress on Pharmacology" to be held during August 07-09, 2017 at Paris, France.

For More details visit: http://pharmacology.pharmaceuticalconferences.com/


Past Reports  Proceedings  Gallery  

Cardiology-2015

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Cardiology 2015 a wonderful event!

Thank you for participating in the 5th International Conference on Clinical & Experimental Cardiology (Cardiology-2015).

It was a great pleasure seeing many familiar faces, several new ones, and many others who have just joined the Cardiology-2015 at the DoubleTree by Hilton Philadelphia Airport, USA.

We hope you had a remarkable time at the conference.

Thank you to all the Honorable Guests, Keynote Speakers, Moderator, Chairs, Co-Chairs, Speakers, Young Researchers, Students, Exhibitors and Delegates, the Organizing Committee and Editorial Board members for their support. The conference would not have been the same without each one of you.
We enjoyed hosting the event and hope you walked away with new ideas, inspiration and ambition to promote work in all possible ways.

Conference Series LLC played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardiological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart DiseasesCongenital Heart DiseasesCardiac Therapeutic AgentsBiophysics and Systems BiologyInterventional CardiologyCancer and HeartCurrent Research in Cardiology and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2015 Organizing Committee would like to thank the Moderators of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital & Kolling Institute, Australia and Dr. Mahazarin Ginwalla, University Hospitals Case Medical Center, USA who contributed a lot for the smooth functioning of this event.

We are also thank full to all the speakers who made this event a grand success, our special thanks to Stacy Masucci, Elsevier and Dr. John E. Strobeck, Daxor Corporation  for exhibiting at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels from Thomas Jefferson University School of Medicine, The Lankenau Heart Institute, USA, Anthony Martin Gerdes from New York Institute of Technology-College of Osteopathic Medicine, USA, Kate M Denton from Monash University, Australia, Yoshiaki Omura from New York Medical College, Heart Disease Research Foundation, USA, Robert M Mentzer from Wayne State University School of Medicine, USA, Karlheinz Seidl from Klinikum Ingolstadt GmbH, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

5th International Conference on Clinical & Experimental Cardiology was a great success with the support of international, multi professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access.


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date Oct 20-21, 2017

Speaker Opportunity

Day 1 Day 2

Media partners & Collaborators

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration